MedTrace Logo

Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

NCT00102752 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2009-04-30

No results posted yet for this study

Summary

The purpose of this study is to determine the safety of glufosfamide when administered in combination with gemcitabine.

Conditions

  • Neoplasms
  • Pancreatic Neoplasms

Interventions

DRUG

Glufosfamide

DRUG

Gemcitabine

Sponsors & Collaborators

  • PPD Development, LP

    collaborator INDUSTRY

  • Threshold Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • United States
  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00102752 on ClinicalTrials.gov